ARCHIVES

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

This article is from The Cancer Letter archive.

Vol. 18 No. 28 | July 10, 1992

Download PDF Visit The Full Archive

Related Articles

Ad Hoc Internet Group Send Rebuttal To Scher’s Letter.

April 27, 2007

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

March 31, 2000

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

NSABP Accrual Slow, But Auditing Called “Impressive”

January 20, 1995

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

January 30, 1976